Related Experiment Video
Updated: Jul 21, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Trends in Stimulant and Sedative/Hypnotic Dispensing: An Exploratory Study.
Harris Liou1, Melanie T Gentry2, Jonathan G Leung2
1Mayo Clinic, Scottsdale, AZ, USA.
Stimulant and sedative co-prescriptions increased significantly over six years, with higher rates observed in non-White patients. This indicates a rise in polypharmacy involving these drug classes.
Area of Science:
- Pharmacology
- Public Health
- Health Services Research
Background:
- Prescribing trends for central nervous system stimulants and sedative-hypnotics are evolving.
- Understanding co-prescription patterns is crucial for patient safety and effective treatment.
Purpose of the Study:
- To analyze trends in co-prescribing stimulants and sedative-hypnotics over a six-year period.
- To identify demographic differences in these co-prescription patterns.
Main Methods:
- Retrospective analysis of institutional pharmacy prescription data from 2015 to 2021.
- Inclusion criteria: patients aged 18+ with at least one stimulant prescription.
- Data collection focused on co-prescribed benzodiazepines or Z-drugs.
Main Results:
- Significant yearly increases in both stimulant dispenses (IRR 1.115) and patients receiving stimulants (IRR 1.090).
- Significant increases in co-prescriptions of stimulants with benzodiazepines (IRR 1.077) and Z-drugs (IRR 1.092).
- Higher increases in co-prescriptions were observed in Non-White patients compared to White patients.
Conclusions:
- Confirms rising stimulant dispensing trends over the past six years.
- Highlights an increase in polypharmacy involving stimulants and sedative-hypnotics.
- Suggests potential disparities in stimulant and sedative co-prescription patterns based on race.
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Barbiturates
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

